CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
20 hedge funds and large institutions have $8.89M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$385K | |
| 2 | +$364K | |
| 3 | +$348K | |
| 4 |
BL
BCWM LLC
Overland Park,
Kansas
|
+$140K |
| 5 |
Citigroup
New York
|
+$82.3K |
Top Sellers
| 1 | -$377K | |
| 2 | -$215K | |
| 3 | -$199K | |
| 4 |
BWA
BDO Wealth Advisors
Jacksonville,
Florida
|
-$75.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$49K |